Knee Arthroplasty Rehabilitation Outcomes Study
| Status: | Completed |
|---|---|
| Conditions: | Orthopedic |
| Therapuetic Areas: | Orthopedics / Podiatry |
| Healthy: | No |
| Age Range: | 40 - Any |
| Updated: | 12/2/2018 |
| Start Date: | October 2014 |
| End Date: | December 31, 2017 |
The objective of the KAROS study is to compare rehabilitation outcomes between 3 proposed
protocols and a current standard of care protocol for the purpose of identifying better
practice for outpatient rehabilitation among patients with single total knee replacement. The
3 advanced protocols involve use of an anti-gravity treadmill and/or the patterned electrical
neuromuscular stimulation (PENS). Both medical modalities have been cleared by the FDA to be
used in medical rehabilitation, including total knee replacement.
protocols and a current standard of care protocol for the purpose of identifying better
practice for outpatient rehabilitation among patients with single total knee replacement. The
3 advanced protocols involve use of an anti-gravity treadmill and/or the patterned electrical
neuromuscular stimulation (PENS). Both medical modalities have been cleared by the FDA to be
used in medical rehabilitation, including total knee replacement.
Inclusion Criteria:
- Patients who undergo an elective single total knee arthroplasty and initiate their
outpatient rehabilitation therapy within 3 weeks after surgery.
- Patients who are 40 years old or older.
- Patients who weight less than 320 lb to accommodate the weight limit to use the
anti-gravity treadmill.
Exclusion Criteria:
- Patients who had any lower extremity joint replacement less than 1 year prior the
current total knee replacement.
- Patients who are pregnant or may be pregnant.
- Patients who have a medical history of neurologic disorders.
- Patients who have received more than 2 weeks of other formats of rehabilitation prior
their outpatient rehabilitation program.
- Patients who received any cancer treatment in the past year prior the current surgery.
- Patients who have uncontrolled cardiovascular hypertension.
- Patients who have cardiac demand pacemakers and/or implanted defibrillators.
We found this trial at
1
site
Click here to add this to my saved trials
